Background Malaria chemoprophylaxis prevents the occurrence of the symptoms of malaria.
Travellers to high-risk Plasmodium falciparum endemic areas need an effective …

A literature review revealed that mefloquine neurotoxicity has been demonstrated at both the
preclinical and clinical levels, with nausea, dizziness, sleep disturbances, anxiety and …

Practice of Travel Medicine: Guidelines by the Infectious Diseases Society of America | Clinical
Infectious Diseases | Oxford Academic Skip to Main Content Advertisement Oxford Academic …

The frequent use of alcohol (ethanol) together with prescription drugs gives any described
pharmacokinetic interaction significant clinical implications. The issue is both the effect of …

Mefloquine (previously marketed in the United States as Lariam®) is an antimalarial
medication with potent psychotropic potential. Severe psychiatric side effects due to …

ContextControversies in malaria prevention arise from the absence of data, conflicting data
between different studies, conflicting recommendations, deviation of local practice from …

Mefloquine for Malaria Chernoprophylaxis 1992—1998: Page 1 Mefloquine for Malaria
Chernoprophylaxis 1992—1998: A Review Patricia Sclilagerzhazrf Summary Metloquine is an …

Abstract Introduction/Objective: Experimental and observational studies have linked
mefloquine use to an increased risk of developing neuropsychiatric adverse effects such as …

Background: The prevalence and features of travel associated neuropsychiatric problems
(NPP) and their relation to previous psychological consultations, antimalarials and …

Background Mefloquine is a clinically important antimalaria drug, which is often not well
tolerated. We critically reviewed 516 published case reports of mefloquine adverse effects …